BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26033668)

  • 41. Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study.
    Rasmussen JB; Knudsen JD; Arpi M; Schønheyder HC; Benfield T; Ostergaard C
    J Antimicrob Chemother; 2014 Feb; 69(2):506-14. PubMed ID: 24078468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adherence to an antibiotic stewardship bundle targeting Staphylococcus aureus blood stream infections at a 200-bed community hospital.
    Borde JP; Batin N; Rieg S; Feik R; Reimling C; Kern WV; de With K; Hübner J; Ruhnke M; Kaier K
    Infection; 2014 Aug; 42(4):713-9. PubMed ID: 24889541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis and management of Staphylococcus aureus bacteraemia.
    Mitchell DH; Howden BP
    Intern Med J; 2005 Dec; 35 Suppl 2():S17-24. PubMed ID: 16271058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of Evidence-Based Care Processes With Mortality in Staphylococcus aureus Bacteremia at Veterans Health Administration Hospitals, 2003-2014.
    Goto M; Schweizer ML; Vaughan-Sarrazin MS; Perencevich EN; Livorsi DJ; Diekema DJ; Richardson KK; Beck BF; Alexander B; Ohl ME
    JAMA Intern Med; 2017 Oct; 177(10):1489-1497. PubMed ID: 28873140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of an antimicrobial stewardship-led intervention for Staphylococcus aureus bacteraemia: a quasi-experimental study.
    Nguyen CT; Gandhi T; Chenoweth C; Lassiter J; Dela Pena J; Eschenauer G; Nagel JL
    J Antimicrob Chemother; 2015 Dec; 70(12):3390-6. PubMed ID: 26338049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Automatic notification and infectious diseases consultation for patients with Staphylococcus aureus bacteremia.
    Djelic L; Andany N; Craig J; Daneman N; Simor A; Leis JA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):282-283. PubMed ID: 29699836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improved outcome with early rifampicin combination treatment in methicillin-sensitive Staphylococcus aureus bacteraemia with a deep infection focus - a retrospective cohort study.
    Forsblom E; Ruotsalainen E; Järvinen A
    PLoS One; 2015; 10(4):e0122824. PubMed ID: 25874546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of infectious diseases consultation for children with Staphylococcus aureus bacteremia.
    Whittington KJ; Ma Y; Butler AM; Hogan PG; Ahmed F; Flowers J; Milburn G; Morelli JJ; Newland JG; Fritz SA
    Pediatr Res; 2022 Dec; 92(6):1598-1605. PubMed ID: 35982140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT.
    Thwaites GE; Scarborough M; Szubert A; Saramago Goncalves P; Soares M; Bostock J; Nsutebu E; Tilley R; Cunningham R; Greig J; Wyllie SA; Wilson P; Auckland C; Cairns J; Ward D; Lal P; Guleri A; Jenkins N; Sutton J; Wiselka M; Armando GR; Graham C; Chadwick PR; Barlow G; Gordon NC; Young B; Meisner S; McWhinney P; Price DA; Harvey D; Nayar D; Jeyaratnam D; Planche T; Minton J; Hudson F; Hopkins S; Williams J; Török ME; Llewelyn MJ; Edgeworth JD; Walker AS
    Health Technol Assess; 2018 Oct; 22(59):1-148. PubMed ID: 30382016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of antimicrobial treatment duration on outcome of Staphylococcus aureus bacteraemia: a cohort study.
    Kim CJ; Song KH; Park KH; Kim M; Choe PG; Oh MD; Lee SH; Jang HC; Kang SJ; Kim HY; Cheon S; Kwak YG; Choi HJ; Kwon KT; Jeon JH; Kim ES; Kim HB;
    Clin Microbiol Infect; 2019 Jun; 25(6):723-732. PubMed ID: 30287412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proactive infectious disease consultation at the time of blood culture collection is associated with decreased mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia: A retrospective cohort study.
    Kawasuji H; Sakamaki I; Kawamura T; Ueno A; Miyajima Y; Matsumoto K; Kawago K; Higashi Y; Yamamoto Y
    J Infect Chemother; 2020 Jun; 26(6):588-595. PubMed ID: 32085966
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
    Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
    Trials; 2019 May; 20(1):250. PubMed ID: 31046810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia.
    Holmes NE; Robinson JO; van Hal SJ; Munckhof WJ; Athan E; Korman TM; Cheng AC; Turnidge JD; Johnson PDR; Howden BP;
    BMC Infect Dis; 2018 Mar; 18(1):107. PubMed ID: 29506483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
    Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Staphylococcus aureus bacteraemia in children and neonates: a 10 year retrospective review.
    Denniston S; Riordan FA
    J Infect; 2006 Dec; 53(6):387-93. PubMed ID: 16476482
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia.
    López-Cortés LE; Del Toro MD; Gálvez-Acebal J; Bereciartua-Bastarrica E; Fariñas MC; Sanz-Franco M; Natera C; Corzo JE; Lomas JM; Pasquau J; Del Arco A; Martínez MP; Romero A; Muniain MA; de Cueto M; Pascual A; Rodríguez-Baño J;
    Clin Infect Dis; 2013 Nov; 57(9):1225-33. PubMed ID: 23929889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Staphylococcus aureus bacteraemia--Nationwide assessment of treatment adequacy and outcome.
    Asgeirsson H; Kristjansson M; Kristinsson KG; Gudlaugsson O
    J Infect; 2011 May; 62(5):339-46. PubMed ID: 21402101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia.
    Hsu MS; Huang YT; Hsu HS; Liao CH
    Clin Microbiol Infect; 2014 Sep; 20(9):892-8. PubMed ID: 24612429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mortality of S. aureus bacteremia and infectious diseases specialist consultation--a study of 521 patients in Germany.
    Rieg S; Peyerl-Hoffmann G; de With K; Theilacker C; Wagner D; Hübner J; Dettenkofer M; Kaasch A; Seifert H; Schneider C; Kern WV
    J Infect; 2009 Oct; 59(4):232-9. PubMed ID: 19654021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of Mortality with Staphylococcus aureus Bacteremia in Elderly Adults.
    Bassetti M; Righi E; Del Giacomo P; Sartor A; Ansaldi F; Trucchi C; Alicino C; Trecarichi EM; Spanu T; Paganino C; Tumbarello M; Carnelutti A
    J Am Geriatr Soc; 2018 Jul; 66(7):1284-1289. PubMed ID: 29664994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.